Why the study?
Does transoesophageal echocardiography identify aortic atheroma as the source of cholesterol embolism in patients with severe CE compared to matched controls?
Does transoesophageal echocardiography identify aortic atheroma as the source of cholesterol embolism in patients with severe CE compared to matched controls?
Transoesophageal echocardiography identifies aortic atheroma as a likely primary source of cholesterol embolism, and systemic steroid therapy may improve prognosis.
Answers are grounded in this paper and cite their sources.
TEE may identify aortic atheroma in cholesterol embolism; supports association but leaves open causal confirmation and practice change.
OBJECTIVES: To examine the thoracic aorta of patients with severe cholesterol embolism (CE) by transoesophageal echocardiography (TOE). METHODS: The thoracic aorta of 20 consecutive patients with CE was compared with that in a control population matched for age and risk factors by TOE. Patients were prescribed steroids after CE was diagnosed. Follow up is reported and compared with results in the literature. RESULTS: Aortic plaques and debris were more common in patients with CE than in the control population (p < 0.001 and p < 0.0001, respectively). The mean (SD) number of aortic plaques in the CE patients was 2.6 (0.7). This aortic atheroma was found predominantly in the descending aorta. One patient died during a mean (SD) follow up of 24 (10) months. CONCLUSIONS: Aortic atheroma, as detected by TOE, should be considered as the main source of CE. In addition, the prognosis in our series, in which steroids were systemically prescribed, is much better than in others reported in the literature.
No takes yet. Share an insight, caveat, or question.
Ferrari et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: